Tamhane Ashutosh, Ambe Girish, Vermund Sten H, Kohler Connie L, Karande Alka, Sathiakumar Nalini
School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Int J Prev Med. 2012 Aug;3(8):569-80.
To determine the factors responsible for patient delay and treatment delay in newly diagnosed sputum smear-positive pulmonary tuberculosis (TB) patients.
Study subjects (N = 150) were randomly selected from municipal health centers in Mumbai, India. Duration of symptoms, treatment, and reason for delay were assessed using interviews and medical records. We defined patient delay as presentation to a health care provider (HCP) >20 days of the onset of TB-related symptoms and treatment delay as therapy initiated more than 14 days after the first consultation (for TB-related symptoms) with an HCP.
Of the 150 subjects, 29% had patient delays and 81% had treatment delays. In multivariable analysis, patient delay was significantly associated with the self-perception that initial symptoms were due to TB [odds ratio (OR) = 3.8, 95% confidence interval (CI) = 1.1-12.6] and perceived inability to pay for care (OR = 2.9, 95% CI = 1.2-7.1). Treatment delay was significantly associated with consulting a non-allopathic provider (OR = 12.3, 95% CI = 1.4-105) and consulting >3 providers (OR = 5.0, 95% CI = 1.4-17.4). Patient interval was half the treatment interval (median days: 15 vs. 31). Women were slightly more likely to experience patient and treatment delays than men. For two-thirds of the patients, another TB patient was a source of TB-related knowledge, while health education material (16%) and television (10%) played a smaller role.
Treatment delay, primarily due to diagnosis delay, was a greater problem than patient delay. Expanding public-public and public-private partnerships and regular training sessions for HCPs might decrease treatment delay. Media coverage and cured TB patients as peer advocates may help to reinforce TB-related health education messages.
确定新诊断的痰涂片阳性肺结核患者出现患者延误和治疗延误的相关因素。
研究对象(N = 150)从印度孟买的市立卫生中心随机选取。通过访谈和病历评估症状持续时间、治疗情况及延误原因。我们将患者延误定义为出现与结核病相关症状>20天后才去看医疗服务提供者(HCP),将治疗延误定义为首次咨询(针对与结核病相关症状)HCP后超过14天才开始治疗。
150名研究对象中,29%出现患者延误,81%出现治疗延误。多变量分析显示,患者延误与认为初始症状是由结核病引起的自我认知显著相关[比值比(OR)= 3.8,95%置信区间(CI)= 1.1 - 12.6]以及认为无力支付医疗费用显著相关(OR = 2.9,95% CI = 1.2 - 7.1)。治疗延误与咨询非对抗疗法提供者显著相关(OR = 12.3,95% CI = 1.4 - 105)以及咨询>3名提供者显著相关(OR = 5.0,95% CI = 1.4 - 17.4)。患者间隔时间是治疗间隔时间的一半(中位数天数:15天对31天)。女性比男性略微更易出现患者延误和治疗延误。三分之二的患者,另一名结核病患者是结核病相关知识的来源,而健康教育材料(16%)和电视(10%)所起作用较小。
主要由于诊断延误导致的治疗延误是比患者延误更大的问题。扩大公私伙伴关系和对HCP进行定期培训可能会减少治疗延误。媒体报道以及治愈的结核病患者作为同伴倡导者可能有助于强化结核病相关健康教育信息。